OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing Fluidigm Technology

    NEXT STORY
    Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
    PREV STORY
    CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

    author_avatar
    NASDAQ Market News

    NewLink Genetics Reports Second Quarter 2017 Financial Results and Updates Indoximod Program

    AMES, Iowa, July 28, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported ...

    author_avatar
    NASDAQ Market News

    Teladoc Health Launches Solution to Address Rising Prescription Drug Costs in Canada

    Using advanced analytics, Best Doctors Specialty Pharmacy Services helps employers and insurers identify and ...

    author_avatar
    NASDAQ Market News